Current Approaches and Future Directions in the Treatment of HER2-positive Breast Cancer

Cancer Treatment Reviews - United Kingdom
doi 10.1016/j.ctrv.2012.04.008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

ID3014 Evaluation of HER2 Status in Breast Cancer: Current Status and Future Directions

Biomedical Research and Therapy
BiochemistryMedicineGeneticsMolecular Biology
2017English

Current Neoadjuvant Treatment Options for HER2 Positive Breast Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2011English

Current Approaches, Challenges and Future Directions for Monitoring Treatment Response in Prostate Cancer

Journal of Cancer
Oncology
2014English

Breast Cancer Chemoprevention: Current Approachesand Future Directions

Current Obstetrics and Gynecology Reports
GynecologyObstetrics
2012English

New Developments in the Treatment of HER2-positive Breast Cancer

Breast Cancer: Targets and Therapy
Oncology
2012English

Emerging Data and Future Directions for CDK4/6 Inhibitor Treatment of Patients With Hormone Receptor Positive HER2-non-amplified Metastatic Breast Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2018English

Optimal Treatment of Early Stage HER2-positive Breast Cancer

Cancer
Cancer ResearchOncology
2018English

Novel Approaches to Target HER2-positive Breast Cancer: Trastuzumab Emtansine

Cancer Management and Research
Oncology
2016English

Targeted Therapeutic Options and Future Perspectives for HER2-positive Breast Cancer

Signal Transduction and Targeted Therapy
Cancer ResearchGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy